Health Care Facilities

IMIC released FY2025 9 Months Earnings on October 29 During-Market (BJT), actual revenue CNY 2.995 B, actual EPS CNY -0.1302

IMIC released FY2025 Q3 earnings on October 29 During-Market (BJT), actual revenue CNY 961.13 M, actual EPS CNY -0.0572

Huaxia Eye released FY2025 Q3 earnings on October 28 Pre-Market (BJT), actual revenue CNY 1.133 B, actual EPS CNY 0.1798

Huaxia Eye released FY2025 9 Months Earnings on October 28 Pre-Market (BJT), with actual revenue of CNY 3.272 B and actual EPS of CNY 0.5198

INKON Life released FY2025 9 Months earnings on October 27 Pre-Market (BJT), actual revenue CNY 1.358 B, actual EPS CNY 0.1166

Bright Eye Hospital Group released FY2025 9 Months Earnings on October 27 After-Market BJT, actual revenue CNY 2.201 B, actual EPS CNY 0.1051

Sanbo released FY2025 Q3 earnings during market hours on October 27 (BJT), with actual revenue of CNY 445.99 M and EPS of CNY 0.0689

INKON Life released FY2025 Q3 earnings on October 27 Pre-Market (BJT), actual revenue CNY 514.81 M, actual EPS CNY 0.0336

Aier released FY2025 9 Months Earnings on October 27 Pre-Market (BJT), actual revenue CNY 17.48 B, actual EPS CNY 0.337

Sanbo released FY2025 9 Months Earnings on October 27 During-Market BJT, actual revenue CNY 1.273 B, actual EPS CNY 0.4096

Bright Eye Hospital Group released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 741.29 M, actual EPS CNY 0.0113

Aier released FY2025 Q3 earnings on October 27 Pre-Market (BJT), actual revenue CNY 5.977 B (forecast CNY 6.349 B), actual EPS CNY 0.1151 (forecast CNY 0.1444)

New Journey released FY2025 9 Months earnings on October 26 After-Market (BJT), actual revenue CNY 2.256 B, actual EPS CNY -0.0114

New Journey released FY2025 Q3 earnings on October 26 After-Market (BJT), actual revenue CNY 668.21 M, actual EPS CNY -0.0136

Innovative Medical released FY2025 Q3 earnings on October 24 After-Market BJT, actual revenue CNY 195.97 M, actual EPS CNY 0.0243

Innovative Medical released FY2025 9 Months Earnings on October 24 After-Market BJT, actual revenue CNY 597.5 M, actual EPS CNY -0.0056

GZYK released FY2025 Q3 earnings on October 23 After-Market (BJT), actual revenue CNY 227.34 M, actual EPS CNY 0

GZYK released FY2025 9 Months Earnings on October 23 After-Market (BJT), Actual Revenue CNY 663.49 M, Actual EPS CNY 0

IMIC to Release FY2025 Q3 Earnings on October 30 During-Market BJT

Huaxia Eye to Release FY2025 Q3 Earnings on October 29, Pre-Market BJT

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

301230

301333

000516

300404

688246

AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma down nearly 15%, and IMIC, BOJI CRO, GOODWILL, and Berry Genomics all dropping more than 5%

Wallstreetcn

R&G Pharma

IMIC

BOJI CRO

GOODWILL

301363

002173

002324

603716

002195

002925

The concept of brain-computer interfaces continues to surge, with Sanbo Brain Science, MeHow, Innovative Medical, PRET, Thalys, Stonehill Technology, and Intretech all experiencing two consecutive trading limits

MeHow

Innovative Medical

PRET

Thalys

Stonehill Technology

Intretech

300753

600775

00553

688626

The concept of brain-computer interfaces opened with a significant surge, with multiple stocks including Sanbo Neuroscience, MeHow, Stonehill Technology, Innovative Medical, and NANJING PANDA hitting the daily limit up. Xiangyu Medical and APON rose over 10%

APON

NPEC

NANJING PANDA

Xiangyu Medical

300015

Aier Eye Hospital to buy stakes in firms

marketscreener

Aier

Aier Eye Hospital to buy stakes in firms

Aier Eye Hospital Group Co., Ltd. appointed Liu Duan and Tian Suhua as independent director at its EGM held on 27 November 2025. .

Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director

Aier Eye Hospital Group Co., Ltd. at its EGM held on 27 November 2025, the company approved 2025 interim profit distribution plan as Cash dividend/10 shares (tax included) of CNY 0.80000000 per share.

Aier Eye Hospital Group Co., Ltd. Approves Interim Dividend of Year 2025

The medical large model innovation company "QuanZhen Medical" announced the completion of 100 million yuan in Series B financing, which includes a strategic round completed by the A-share listed company Innovative Medical in the fourth quarter of 2024 and a Series B round completed by Good Doctor Group in the second quarter of 2025. Probe Capital served as the exclusive financial advisor. After the financing, QuanZhen Medical will increase its investment in research and development, upgrade its products, and enhance its AI support capabilities

36Kr

"Quanzhen Medicine" secures 100 million yuan in Series B financing

Aier Eye Hospital Group Co., Ltd. announced that at the EGM to be held on 27 November 2025, the company proposed 2025 interim profit distribution plan as Cash dividend/10 shares (tax included): CNY 0.80000000.

Aier Eye Hospital Group Co., Ltd. Proposes Interim Profit Distribution Plan for 2025

Aier Eye Hospital announces interim dividend plan

Aier Eye Hospital announces interim dividend plan

301267

Certain A Shares of Huaxia Eye Hospital Group Co., Ltd. are under a Lock-Up Agreement until 7-NOV-2025, lasting 1109 days from 25-OCT-2022. Key stakeholders, including the actual controller and various shareholders, have committed to not transferring their shares for specified periods post-listing. If share prices fall below the issuance price for consecutive trading days, the lock-up may extend. After expiration, they can only transfer 25% of their shares annually while in office.

Huaxia Eye

Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2025.

000409

Next week, 30 stocks will be unlocked, with a total unlocked market value of 20.322 billion yuan. Huaxia Eye will unlock 511 million shares, with a market value of 9.993 billion yuan, the highest unlock scale. Yunding Tech will unlock 153 million shares, with a market value of 1.74 billion yuan, the second highest unlock scale. Huaxia Eye has the highest unlock ratio, reaching 60.85%

Zhitong

Yunding Tech

30 stocks will face lifting of restrictions next week

According to the Zhitong Finance APP, Aier released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 17.484 billion yuan, a year-on-year increase of 7.25%. The net profit attributable to shareholders of the listed company was 3.115 billion yuan, a year-on-year decrease of 9.76%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.119 billion yuan, a year-on-year increase of 0.20%. The basic earnings per share were 0.337 yuan

Aier Eye Hospital released its performance for the first three quarters, with a net profit attributable to the parent company of 3.115 billion yuan, a decrease of 9.76%

301293

Sanbo Neuroscience released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 1.273 billion yuan, a year-on-year increase of 20.26%. The net profit attributable to the parent company was 83.6282 million yuan, a year-on-year decrease of 20.01%; the net profit after deducting non-recurring gains and losses was 84.9638 million yuan, a year-on-year decrease of 4.85%. The basic earnings per share were 0.41 yuan

Sanbo

Sanbo Neuroscience released its performance for the first three quarters, with a net profit attributable to the parent company of 83.6282 million yuan, a decrease of 20.01%

Health Care Facilities(IN40181.SH)

AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma down nearly 15%, and IMIC, BOJI CRO, GOODWILL, and Berry Genomics all dropping more than 5%

The concept of brain-computer interfaces continues to surge, with Sanbo Brain Science, MeHow, Innovative Medical, PRET, Thalys, Stonehill Technology, and Intretech all experiencing two consecutive trading limits

The concept of brain-computer interfaces opened with a significant surge, with multiple stocks including Sanbo Neuroscience, MeHow, Stonehill Technology, Innovative Medical, and NANJING PANDA hitting the daily limit up. Xiangyu Medical and APON rose over 10%

Aier Eye Hospital to buy stakes in firms

Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director